Data / Form D filings / Octagon Therapeutics, Inc.
Octagon Therapeutics, Inc.: Form D filings
Octagon Therapeutics, Inc., a pharmaceuticals company in Providence, RI, filed 4 Form D notices with the SEC between 2018 and 2024. The latest, on February 12, 2024, reports $11 million sold of a $12.4 million offering to 53 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 225 DYER ST., Providence, RI, 02903
- Phone
- (857) 488-3417
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1756982
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | New notice | $12,410,030 | $10,970,135 | $1,439,895 | 53 | Jan 29, 2024 | sec.gov |
| Jun 10, 2020 | New notice | $1,000,000 | $398,000 | $602,000 | 8 | Jun 1, 2020 | sec.gov |
| Nov 26, 2019 | New notice | $511,000 | $511,000 | 10 | Nov 15, 2019 | sec.gov | |
| Oct 25, 2018 | New notice | $1,000,000 | $537,588 | $462,412 | 2 | Oct 15, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Isaac Stoner | Executive Officer, Director | |
| Thorne Sparkman | Director | |
| Ronald Lennox | Director |
Every Form D from the week of Feb 12, 2024 · All recent filings in Rhode Island · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Octagon Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.